Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario
Clinical trial NCT02177721 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02177721
- Sponsor
- Emergent BioSolutions
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-01
- Primary completion
- 2035-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.